All Peptides
MK-677
Ibutamoren
MK-677 (Ibutamoren) is a non-peptidic, potent, long-acting, orally-active, and selective agonist of the ghrelin receptor and a growth hormone secretagogue.
AOD-9604
hGH Fragment 177–191
C-terminal fragment of human growth hormone (hGH177–191), lyophilized, research grade. Each vial contains 5 mg AOD-9604 with ≥98% purity by HPLC-MS.
Methylcobalamin (B12)
Vitamin B12 — Methylcobalamin Form
Methylcobalamin, the active coenzyme form of Vitamin B12, supplied as a lyophilized white powder for reconstitution. Research grade, ≥99% purity.
BPC-157
Body Protection Compound-157
Pentadecapeptide BPC-157 (GEPPPGKPADDAGLV), lyophilized, 10 mg per vial. ≥99% purity by HPLC-MS. Each 10-pack ships with sterile vials.
BPC-157 Capsules
Body Protection Compound-157 Oral Format
BPC-157 in lyophilized capsule format. 500 mcg per capsule, 100 capsules per unit. ≥99% purity by HPLC.
BPC-157 / TB-500
Body Protection Compound + Thymosin Beta-4 Analog Blend
Co-lyophilized blend of BPC-157 (5 mg) and TB-500 synthetic analog (5 mg) per vial. ≥99% combined purity by HPLC-MS.
CJC-1295 (No DAC) / Ipamorelin
GHRH Analog + GH Secretagogue Receptor Agonist Blend
Co-lyophilized blend of CJC-1295 No DAC (5 mg) and Ipamorelin (5 mg) per vial. ≥98% purity by HPLC-MS.
CJC-1295 (No DAC)
Modified GRF(1-29) — Growth Hormone Releasing Hormone Analog
Modified GRF(1-29) without Drug Affinity Complex (No DAC). 10 mg lyophilized per vial. ≥98% purity by HPLC-MS.
DSIP
Delta Sleep-Inducing Peptide
Delta Sleep-Inducing Peptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu), 5 mg lyophilized per vial. ≥99% purity by HPLC. Under PCAC review Jul 2026.
Epitalon
Epithalon — Tetrapeptide (Ala-Glu-Asp-Gly)
Tetrapeptide Epitalon (Ala-Glu-Asp-Gly), 10 mg lyophilized per vial. ≥98% purity by HPLC-MS. PCAC review Jul 2026.
GHK-Cu
Copper Peptide — Glycyl-L-Histidyl-L-Lysine Copper(II)
GHK-Cu (Gly-His-Lys copper complex), 100 mg lyophilized per vial. ≥99% purity by HPLC-MS.
GLOW Blend
BPC-157 + TB-500 + GHK-Cu Tri-Peptide Complex
Proprietary tri-peptide blend: BPC-157, TB-500 synthetic analog, and GHK-Cu co-lyophilized per vial. ≥99% purity. Proprietary ratio.
Ipamorelin
GH Secretagogue Receptor Agonist (Penta-Peptide)
Ipamorelin (Aib-His-D-2Nal-D-Phe-Lys-NH₂), 10 mg lyophilized per vial. ≥99% purity by HPLC-MS.
Kisspeptin-10
Metastin(45-54) — GPR54 Receptor Ligand
Kisspeptin-10 (human sequence), 10 mg lyophilized per vial. ≥98% purity by HPLC-MS.
KLOW Blend
KPV + BPC-157 + TB-500 + GHK-Cu Quad-Peptide Complex
Proprietary quad-peptide blend: KPV, BPC-157, TB-500, and GHK-Cu co-lyophilized per vial. ≥98% combined purity.
MOTS-c (10 mg)
Mitochondrial Open Reading Frame of the 12S rRNA-c
MOTS-c (mitochondrial peptide), 10 mg lyophilized per vial. ≥98% purity by HPLC-MS. PCAC review Jul 2026.
MOTS-c (40 mg)
Mitochondrial Open Reading Frame of the 12S rRNA-c — High Dose
MOTS-c, 40 mg lyophilized per vial (high-dose research format). ≥98% purity by HPLC-MS.
NAD⁺ (1000 mg)
Nicotinamide Adenine Dinucleotide — High Concentration
NAD⁺ (oxidized form), 1000 mg lyophilized per vial. ≥99% purity by HPLC. High-concentration research format.
NAD⁺ (500 mg)
Nicotinamide Adenine Dinucleotide — Standard Concentration
NAD⁺ (oxidized form), 500 mg lyophilized per vial. ≥99% purity by HPLC.
Retatrutide (10 mg)
GLP-1/GIP/Glucagon Triple Agonist (LY3437943)
Retatrutide (LY3437943), 10 mg lyophilized per vial. Triple GLP-1R/GIPR/GcgR receptor agonist. ≥98% purity by HPLC-MS.
Retatrutide (20 mg)
GLP-1/GIP/Glucagon Triple Agonist (LY3437943) — High Dose
Retatrutide (LY3437943), 20 mg lyophilized per vial. High-dose research format. ≥98% purity by HPLC-MS.
Sermorelin
GRF(1-29)NH₂ — Growth Hormone Releasing Factor
Sermorelin acetate (hGRF 1-29), 5 mg lyophilized per vial. ≥99% purity by HPLC-MS.
TB-500
Thymosin Beta-4 Synthetic Analog (Actin Sequestering Peptide)
TB-500 (Thymosin Beta-4 synthetic analog), 10 mg lyophilized per vial. ≥99% purity by HPLC-MS. PCAC review Jul 2026.
Tesa / CJC / IPA Triple
Tesamorelin + CJC-1295 No DAC + Ipamorelin Triple Blend
Tri-peptide co-lyophilized blend: Tesamorelin (6 mg) + CJC-1295 No DAC (3 mg) + Ipamorelin (3 mg) per vial. ≥98% purity.
Tesamorelin / Ipamorelin
GHRH Analog + GHS-R Agonist Dual Blend (5 mg / 5 mg)
Co-lyophilized dual blend: Tesamorelin (5 mg) + Ipamorelin (5 mg) per vial. ≥98% purity by HPLC-MS.
Tesamorelin
Trans-3-Hexenoic Acid-GRF(1–44) — GHRH Analog
Tesamorelin, 10 mg lyophilized per vial. Modified GHRH analog with hexenoic acid conjugate. ≥98% purity by HPLC-MS.
Tesamorelin / Ipamorelin (6/3)
GHRH Analog + GHS-R Agonist Dual Blend (6 mg / 3 mg)
Co-lyophilized dual blend: Tesamorelin (6 mg) + Ipamorelin (3 mg) per vial. Asymmetric ratio for receptor saturation studies. ≥98% purity.
Tirzepatide
GLP-1/GIP Dual Agonist
Tirzepatide, 10 mg lyophilized per vial. A dual GIP/GLP-1 receptor (GIPR/GLP-1R) agonist — not GLP-1 itself. ≥98% purity by HPLC-MS.
GLP-2
Glucagon-Like Peptide-2 — Intestinotrophic Peptide (Teduglutide Analog)
Glucagon-Like Peptide-2 (GLP-2), 5 mg lyophilized per vial. A distinct intestinotrophic proglucagon-derived peptide (teduglutide analog) acting on the GLP-2 receptor — unrelated to the incretin GLP-1/GIP agonists. Research standard for intestinal epithelial growth and receptor binding assays. ≥98% purity.